Pharmaceutical Preparation Manufacturing
NAICS 325412 · Federal Contracts & Awards
Companies in the Pharmaceutical Preparation Manufacturing industry (NAICS code 325412) have received $59.83B in federal contracts, grants, and other awards since FY2024, across 51K individual awards tracked through FY2026. The largest funding agency is Department of Health and Human Services ($32.28B). Spending is concentrated in Texas, Tennessee, New Jersey and 49 other states. All figures below come from USAspending.gov award records.
Total Obligations
$59.83B
Total Awards
51K
States
52
Last Updated
Apr 23, 2026
Yearly Spending Trend
$29.74B24
$23.87B25
$6.22B26
Top 50 Awards in Pharmaceutical Preparation Manufacturing
Largest individual obligations in NAICS 325412.
| Award | Recipient | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|---|
CONT_IDV_75D30125D00195_7523 VACCINES FOR CHILDREN FY25 | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $2,461,522,172 |
CONT_IDV_75D30123D16108_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,437,840,442 |
CONT_IDV_75D30124D18656_7523 2024-2025 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,342,411,113 |
CONT_IDV_75D30122D13472_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,167,201,004 |
CONT_IDV_75D30121D10575_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,887,935,043 |
CONT_IDV_75D30125D00196_7523 VACCINES FOR CHILDREN FY25 | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,428,549,577 |
CONT_AWD_36C24026K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,406,868,182 |
CONT_IDV_75D30124D18658_7523 2024-2025 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,277,794,494 |
CONT_IDV_75D30121D10579_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,211,607,191 |
CONT_IDV_75D30120D07516_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,203,870,828 |
CONT_AWD_36C24026K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,184,200,532 |
CONT_AWD_36C24025K1012_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,177,854,443 |
CONT_IDV_75D30122D13473_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,136,023,848 |
CONT_AWD_36C24025K1010_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,118,034,560 |
CONT_AWD_36C24026K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,110,402,104 |
CONT_AWD_36C24026K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,087,989,766 |
CONT_AWD_36C24025K1011_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,075,377,430 |
CONT_AWD_36C24025K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,047,972,072 |
CONT_AWD_36C24025K1007_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,045,889,952 |
CONT_AWD_36C24025K1008_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MAY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,043,484,625 |
CONT_AWD_75D30122C14691_7523_-NONE-_-NONE- VACCINE DISTRIBUTION | MCKESSON SPECIALTY DISTRIBUTION LLC Tennessee | Department of Health and Human Services Centers for Disease Control and Prevention | — | MEMPHIS, TN-09 | 2024 | $1,029,830,184 |
CONT_AWD_HHSO100201700019C_7505_-NONE-_-NONE- BAVARIAN NORDIC MOD 19 | BAVARIAN NORDIC A/S | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $1,023,713,981 |
CONT_AWD_36C24025K1009_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JUNE | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,020,312,793 |
CONT_AWD_36C24025K1006_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $999,993,461 |
CONT_IDV_75D30124D18657_7523 2024-2025 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $990,091,120 |
CONT_AWD_36C24024K1010_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JULY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $971,836,194 |
CONT_AWD_36C24024K1012_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $953,242,300 |
CONT_AWD_36C24024K1011_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $943,800,292 |
CONT_IDV_75D30125D00194_7523 END OF PWS | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $920,931,033 |
CONT_AWD_36C24025K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $911,976,278 |
CONT_AWD_36C24024K1006_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MARCH | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $851,413,499 |
CONT_AWD_36C24024K1009_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JUNE | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $838,785,945 |
CONT_IDV_75D30120D07513_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $797,495,916 |
CONT_IDV_75D30125D00198_7523 VACCINES FOR CHILDREN FY25 | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $793,017,790 |
CONT_IDV_75D30124D18655_7523 2024-2025 VACCINES FOR CHILDREN | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $771,185,425 |
CONT_AWD_36C24025K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $715,986,475 |
CONT_IDV_75D30123D16109_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $706,670,327 |
CONT_AWD_75A50120C00092_7505_-NONE-_-NONE- THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE | PHLOW CORP. Virginia | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | RICHMOND, VA-04 | 2024 | $696,665,954 |
CONT_AWD_36C24025K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $659,105,031 |
CONT_AWD_36C24025K1005_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 FEBRUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $633,609,362 |
CONT_AWD_36C24024K1008_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MAY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $620,873,014 |
CONT_AWD_36C24024K1007_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 APRIL | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $610,147,795 |
CONT_AWD_36C24024K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $608,690,886 |
CONT_AWD_36C24024K1005_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 FEBRUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $567,909,092 |
CONT_AWD_36C24024K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $559,366,956 |
CONT_AWD_36C24024K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $545,407,050 |
CONT_AWD_36C24024K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $536,861,081 |
CONT_AWD_SPE2DS22F0022_9700_SPE2DE21D0050_9700 8508632124!QUICKVUE AT-HOME OTC COVID-19 | QUIDEL CORP California | Department of Defense Defense Logistics Agency | — | SAN DIEGO, CA-51 | 2024 | $521,374,748 |
CONT_AWD_75A50119C00037_7505_-NONE-_-NONE- VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS. | EMERGENT BIOSOLUTIONS CANADA INC | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $422,315,784 |
CONT_IDV_75D30126D20729_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2026 | $361,340,130 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Top Funding Agencies
View All→12345678910
Department of Health and Human Services$32.28B
Department of Veterans Affairs$25.79B
Department of Defense$1.19B
Department of Justice$553.0M
Department of Homeland Security$6.0M
Peace Corps$3.5M
Department of State$2.9M
Department of Agriculture$2.3M
Department of the Interior$900K
Department of Commerce$234K
Top Recipients
View All→Spending by State
| State | Funding | Awards |
|---|---|---|
| Texas | $25.70B | 7K |
| Tennessee | $1.23B | 522 |
| New Jersey | $991.5M | 676 |
| Virginia | $798.5M | 434 |
| California | $796.7M | 689 |
| Florida | $654.0M | 425 |
| Pennsylvania | $542.2M | 566 |
| Massachusetts | $367.6M | 382 |
| New York | $277.9M | 4K |
| Illinois | $202.3M | 22K |
| Oklahoma | $181.5M | 64 |
| Arizona | $129.9M | 116 |
| Ohio | $105.9M | 10K |
| Missouri | $80.0M | 313 |
| Maryland | $61.0M | 211 |
| Georgia | $54.0M | 122 |
| New Mexico | $51.9M | 43 |
| North Carolina | $41.4M | 187 |
| Michigan | $11.4M | 56 |
| Indiana | $10.5M | 28 |
| Iowa | $9.4M | 32 |
| District of Columbia | $9.2M | 10 |
| Kentucky | $8.7M | 40 |
| Kansas | $7.9M | 29 |
| Nevada | $7.8M | 26 |
| Mississippi | $5.7M | 22 |
| Utah | $5.6M | 38 |
| Connecticut | $5.5M | 17 |
| West Virginia | $4.2M | 30 |
| Colorado | $4.0M | 31 |
| Washington | $3.9M | 51 |
| South Carolina | $3.5M | 212 |
| Louisiana | $3.4M | 9 |
| Alabama | $2.7M | 10 |
| Arkansas | $2.6M | 8 |
| Minnesota | $2.6M | 12 |
| Hawaii | $2.5M | 17 |
| Wisconsin | $1.7M | 13 |
| North Dakota | $1.7M | 3 |
| South Dakota | $1.3M | 7 |
| Nebraska | $1.2M | 16 |
| Wyoming | $1.1M | 2 |
| Vermont | $845K | 5 |
| Maine | $826K | 4 |
| Oregon | $747K | 11 |
| Delaware | $742K | 12 |
| Guam | $607K | 5 |
| Montana | $484K | 4 |
| Idaho | $428K | 7 |
| New Hampshire | $401K | 5 |
| Rhode Island | $311K | 3 |
| Alaska | $141K | 1 |
Source: USAspending.gov · All Industries